1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
CLS Holdings USA, Inc.

CLS Holdings USA, Inc.

CLSH.CN
CLS Holdings USA, Inc.CA flagCanadian Securities Exchange
0.04
CAD
-0.01
- -
8.11MMarket Cap
CLS Holdings USA, Inc.
CLSH.CN
(Canadian Securities Exchange)

Recent

price

0.04

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
- -
- -
- -
- -
- -
- -
0.33
0.38
0.61
0.71
0.38
0.2
0.14
Revenue per Share
- -
-0.01
-0.95
-0.52
-0.94
-0.98
-1.07
-0.97
-0.5
-0.07
-0.23
-0.05
-0.03
Basic EPS, GAAP
- -
-0.01
-0.5
-0.25
-0.23
-0.15
-0.44
-0.16
-0.09
-0.13
-0.01
0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.01
-0.95
-0.82
-1.73
-1.89
-1.8
-2.43
-2.93
-2.97
-1.79
-1.15
-0.83
Book Value per Share
- -
-0.01
-0.37
-0.28
-0.36
-0.06
-0.09
-0.23
-0.54
-0.59
-0.24
-0.14
-0.09
Tangible Book Value per Share
3
3
2
5
5
10
26
32
32
32
61
99
137
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
8
12
19
23
23
20
19
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
-270.12
-23.65
-5.98
-3.87
-5.63
-5.31
-8.07
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
Depreciation Expense
- -
- -
-2
-3
-5
-10
-28
-31
-16
-2
-14
-4
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
154.77
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
-326.5
-257.25
-82.37
-10.34
-59.65
-22.48
-19.5
Profit Margin (%)
- -
- -
-1
-1
-2
-3
6
6
-1
-21
-12
-11
-13
Working Capital
- -
- -
- -
- -
- -
- -
15
19
22
5
8
7
3
LT Debt
- -
- -
-1
-1
-2
-1
25
-5
-15
-17
-14
-13
-12
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.6
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
May'24
Aug'25
Nov'25
ST Debt
2
2
2
LT Borrowings
5
5
2
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
125
181
165
Market Capitalization
4
5
9

Working Capital

FRC

•

in mil. unless spec.
May'24
Aug'25
Nov'25
Total Current Assets
3
6
4
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
1
1
1
Inventories
2
2
2
Total Current Liabilities
14
16
17
Payables & Accruals
12
14
14
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-210.4%
9.17%
-6.46%
Free Cash Flow
567.58%
-82.28%
-272.86%
Net Income, GAAP
607.06%
59.81%
-67.48%
Sales/Revenue/Turnover
- -
21.72%
-13.71%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
6
6
5
6
23
2024
5
5
5
5
20
2025
5
4
4
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.04
-0.12
-0.01
- -
-0.23
2024
-0.01
-0.02
-0.04
- -
-0.05
2025
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Gufic Biosciences Limited (GUFICBIO.BO)
Ipca Laboratories Limited (IPCALAB.NS)
Evotec SE (EVT.DE)
Simply Solventless Concentrates (HASH.V)
Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)
Univec, Inc. (UNVC)
Business
CLS Holdings USA, Inc. is a diversified cannabis company operating primarily in Nevada as a fully licensed, vertically integrated producer, manufacturer, and retailer under the brand Cannabis Life Sciences. Its core products and services include the extraction of cannabinoids from cannabis plants, manufacturing cannabis concentrates such as waxes, shatter, and edibles, and retailing cannabis products through its Oasis dispensary. The company’s business model encompasses licensing operations, processing facilities, product sales, brand creation, and consulting services. It operates key brands including City Trees, Nevada's top-selling vape brand, and Oasis, one of Las Vegas’ premier cannabis dispensaries. CLS Holdings targets both local residents and tourists within the Nevada market and is expanding its product distribution to additional states such as New York. Founded in 2015 and headquartered in Las Vegas, Nevada, CLS Holdings has recently undertaken significant strategic initiatives including a reverse stock split approved in mid-2025 to consolidate its shares. In 2024 and 2025, the company focused on debt reduction, repurchasing over $1.5 million in principal and interest obligations to strengthen shareholder value. CLS also executed a comprehensive revitalization of the City Trees brand, refreshing its product offerings to maintain market leadership. The company expanded its market footprint by entering New York’s recreational cannabis market, marking its second major state expansion after Nevada. In addition, CLS Holdings has pursued share repurchases to reduce outstanding shares and improve capital structure and formed a partnership with AE Global, reflecting a strategic emphasis on growth and operational efficiency. CLS Holdings USA, Inc. operates in the cannabis industry segment, serving consumers and retailers with a focus on high-quality cannabinoid extraction and branded cannabis products. The company maintains its operations in Nevada while strategically expanding into other U.S. states through licensing and product distribution channels. The firm is publicly traded on the OTC market under the ticker CLSH and on the Canadian Securities Exchange (CSE). Its subsidiaries include Oasis Dispensary and City Trees, which support its integrated production-to-retail value chain. CLS Holdings continues to invest in brand innovation, product development, and financial restructuring to solidify its market position amid evolving cannabis industry regulations and competitive dynamics.